Taflotan 0.0015% 0.3ml #30

Taflotan user manual

Reed more and buy Taflotan on this page

Form of formulation and composition of the preparation

The drug Taflotan is available in the form of eye drops in dosage tubes of 0.3 ml in volume, soldered together as a plastic tape. The preparation is packed in a cardboard box with the attached detailed description.
In 1 ml of the drug, Taflotan contains 15 μg of active substance Tafluprost, as well as a number of excipients.

Indications for use

The drug Taflotan is intended for instillation into the eye. Drops are prescribed to patients for symptomatic treatment of open-angle glaucoma and increased intraocular pressure in the complex therapy.

Contraindications

Before starting the use of the drug, the patient should consult an ophthalmologist and carefully study the accompanying instructions to the drug. Drops of Taflotan can not be instilled in the eyes with individual intolerance to the components, as well as to patients under the age of 18, pregnant women and nursing mothers.

Dosing and Administration

According to the instructions of the drop, Taflotan is instilled in each conjunctival sac 1-2 drops once a day, best at night.
The contents of a single dropper package are sufficient for instilling the drug in both eyes. The remaining drops in the tube should be immediately discarded and the next time you open a new dropper package.
Before instillation of the drug is recommended to thoroughly wash your hands with soap. To avoid infection, do not touch the dropper with your hands. Excess preparations after instillation should be immediately removed with a vaginal swab.
With the simultaneous appointment of several types of drops to the patient, wait for at least 5 minutes between instillations.

Use of the drug during pregnancy and breastfeeding

Safety of the drug Taflotan for pregnant women and the fetus growing in the womb is not established, therefore, drops are not prescribed for treatment of women during the period of gestation of the baby.
During the experimental studies on laboratory rats, it was found that tafluprost may have an adverse effect on the fetus or course of pregnancy in general.
Women who use these eye drops to treat glaucoma should abstain from pregnancy and use effective contraception.
Data on the ability of the drug Taflotan excreted in breast milk is not provided, so drops are not prescribed for the treatment of nursing mothers. If therapy is necessary, the question of cessation of lactation should be resolved.

Side effects

Usually the drug is normally tolerated by patients, however, in individuals with increased individual sensitivity to the components of drops, side effects may develop:
    itching of the eyelids;
    swelling of the eyelids;
    hyperemia of the mucous membranes;
    rashes on the eyelids;
    change in eyelash growth;
    foreign body sensation in the eye;
    severe burning after instillation;
    increased secretions from the eye;
    decreased visual acuity;
    allergic conjunctivitis and blepharitis.
In rare cases, with droplets in the eyes, patients develop headaches and hypertrichosis.

An overdose of the drug

Cases of drug overdose is unlikely even with prolonged use of drops, but in order to avoid the development of these side effects do not exceed the dose indicated in the instructions.
When the symptoms of an overdose develop, the drug is stopped and symptomatic treatment is performed.

Interaction of the drug with other drugs

No data on drug interactions Taflotan preparation with other ophthalmic medicines local action, but if the patient is already using any medication, you should be sure to inform your doctor.

special instructions for Taflotan

Before starting the use of the drug the patient should be warned that against the background of therapy with drops it is possible to increase the growth of eyelashes and change the color of the upper eyelid. Sometimes such changes occur only in the area of ​​one eye, but soon after the withdrawal of treatment the drug passes by itself.
Against the background of prolonged use of the drug in the patient, the pigmentation of the iris may change, which is more common in one eye and occurs within a few months after discontinuation of therapy.
Patients wearing contact lenses should consult a physician before using drops. Usually during the instillation of the drug, the lenses are removed and inserted back only an hour after the use of the drops.
As after the instillation of the drug in the eyes of patients experience transient blurred vision and blurred sight, the therapy should be careful when driving and the management of complex technology requiring a rapid response.

Leave and storage conditions

To buy Taflotan you don't need a prescription from a doctor. The optimum temperature for storing eye drops is from 2 to 10 degrees above zero. The shelf life of the drug is indicated on the packaging and is 3 years from the date of manufacture. After opening the package with a tube-dropper, the drug can be stored in the refrigerator for no more than 30 days.